Sarepta Therapeutics, Inc. (SRPT)
NasdaqGS • Currently down 0.16 (-0.94%) in today's trading session
2 members of Congress have disclosed 10 trades in Sarepta Therapeutics, Inc. (SRPT) via STOCK Act filings. The most recent disclosure was a sale by Gilbert Cisneros on 14 April 2025. The most active traders have been Gilbert Cisneros (9) and Josh Gottheimer (1). Aggregate disclosed activity totals roughly $64K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).
Sarepta Therapeutics, Inc. is currently trading at $16.80, positioned at 19% of its 52-week range ($10.42 – $43.92).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Not available in the US.
Past Performance is not an indication of future results.
*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.
Sarepta Therapeutics, Inc. Price History and Technical Analysis
Congressional Trading Activity for SRPT
| Gilbert Cisneros | 14 Apr 2025 | 6 May 2025 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Josh Gottheimer | 6 Mar 2023 | 20 Apr 2023 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 14 Sept 2020 | 14 Oct 2020 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 10 Jun 2020 | 17 Jul 2020 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 11 Oct 2019 | 15 Nov 2019 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 10 Oct 2019 | 15 Nov 2019 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 9 Apr 2019 | 14 May 2019 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 11 Mar 2019 | 16 Apr 2019 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 27 Feb 2019 | 8 Mar 2019 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Gilbert Cisneros | 26 Feb 2019 | 8 Mar 2019 | Purchase | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
LLY
Eli Lilly and Company
JNJ
Johnson & Johnson
AAPL
Apple Inc.
Frequently Asked Questions about SRPT
- Which members of Congress have traded SRPT?
- 2 members of Congress have disclosed 10 trades in Sarepta Therapeutics, Inc. (SRPT) under the STOCK Act. The most active traders are Gilbert Cisneros and Josh Gottheimer.
- When was SRPT most recently disclosed by Congress?
- The most recent SRPT disclosure was a sale by Gilbert Cisneros on 14 April 2025.
- What is the total disclosed congressional trading volume for SRPT?
- Members of Congress have disclosed approximately $64K in SRPT purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
- How can I track new congressional trades in SRPT?
- This SRPT page updates as soon as new STOCK Act disclosures are filed for Sarepta Therapeutics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track SRPT in Congress
See when politicians buy or sell this stock